Published in Int Urol Nephrol on January 01, 2004
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis. Int Urol Nephrol (2009) 9.91
Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int (2002) 2.24
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int (2006) 1.68
Dialysis modality choices among chronic kidney disease patients: identifying the gaps to support patients on home-based therapies. Int Urol Nephrol (2010) 1.61
The use of nocturnal home hemodialysis as salvage therapy for patients experiencing peritoneal dialysis failure. Perit Dial Int (2007) 1.45
Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J (2005) 1.41
Vitamin D status in patients with recurrent kidney stones. Nephron Clin Pract (2013) 1.40
Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant (2008) 1.35
Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol (2011) 1.28
High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int (2008) 1.26
J-wave formation in patients with acute intracranial hypertension. J Electrocardiol (2009) 1.14
Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study. Perit Dial Int (2008) 1.14
Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects. Clin Exp Pharmacol Physiol (2007) 1.07
Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol (2003) 1.02
Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature. Int Urol Nephrol (2007) 1.02
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol (2008) 1.00
Encapsulating peritoneal sclerosis: a single-center experience and review of the literature. Int Urol Nephrol (2010) 0.99
Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol (1985) (2005) 0.99
Geriatric nephrology is coming of age. J Am Soc Nephrol (2003) 0.98
Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis. Int Urol Nephrol (2007) 0.97
Assisted peritoneal dialysis: what is it and who does it involve? Adv Perit Dial (2009) 0.94
Fatigue in chronic peritoneal dialysis patients. Int Urol Nephrol (2003) 0.94
Asymmetric properties of long-term and total heart rate variability. Med Biol Eng Comput (2011) 0.93
The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol (2008) 0.93
Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int (2003) 0.92
Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity. Transl Res (2009) 0.92
Peritoneal dialysis in patients with acute renal failure. Adv Perit Dial (2007) 0.91
Normal saline induces oxidative stress in peritoneal mesothelial cells. J Pediatr Surg (2008) 0.91
25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol (2006) 0.90
Asymmetrical properties of heart rate variability in type 1 diabetes. Clin Auton Res (2010) 0.90
Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg (2004) 0.90
The effect of a Tai Chi exercise program on quality of life in patients on peritoneal dialysis: a pilot study. Perit Dial Int (2005) 0.89
Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl (2003) 0.89
Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients >or=65 years of age. Am J Cardiol (2006) 0.88
Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med (2006) 0.87
Anti-inflammatory effect of sulodexide during acute peritonitis in rats. Blood Purif (2008) 0.86
Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic. Int Urol Nephrol (2008) 0.86
Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se. Perit Dial Int (2003) 0.86
Peritoneal dialysis in congestive heart failure. Adv Perit Dial (2007) 0.85
K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them? Int Urol Nephrol (2006) 0.85
Chronic peritoneal dialysis in the elderly. Semin Dial (2002) 0.85
Sources of variation in estimates of lean body mass by creatinine kinetics and by methods based on body water or body mass index in patients on continuous peritoneal dialysis. J Ren Nutr (2009) 0.85
Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study. Int Urol Nephrol (2014) 0.85
Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data. Int Urol Nephrol (2010) 0.85
Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int (2006) 0.85
Exercise training slows down heart rate and improves deceleration and acceleration capacity in patients with heart failure. J Electrocardiol (2012) 0.84
Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant (2004) 0.84
Coronary artery bypass grafting in patients on maintenance dialysis: is peritoneal dialysis a risk factor of operative mortality? Int Urol Nephrol (2008) 0.84
Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion. Adv Perit Dial (2002) 0.83
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Int Urol Nephrol (2012) 0.83
Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int (2002) 0.83
Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism. Int Urol Nephrol (2008) 0.83
Correlation between the donor age and the proliferative lifespan of human peritoneal mesothelial cells in vitro: is TGF-beta1 a link? Exp Gerontol (2007) 0.83
Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? Int Urol Nephrol (2006) 0.83
Home dialysis first: a new paradigm for new ESRD patients. J Nephrol (2011) 0.82
Assisted peritoneal dialysis as a method of choice for elderly with end-stage renal disease. Int Urol Nephrol (2008) 0.82
The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults. Free Radic Res (2007) 0.82
Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int (2004) 0.82
Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol Dial Transplant (2008) 0.82
Incidence of end-stage renal disease in the elderly: a steadily rising global socioeconomic epidemic. Int Urol Nephrol (2009) 0.82
Effects of glutathione supplementation during peritoneal dialysis. Adv Perit Dial (2006) 0.82
Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation. Br J Clin Pharmacol (2007) 0.81
Diabetic patients on peritoneal dialysis. Semin Dial (2010) 0.81
Arterial stiffness, central hemodynamics and wave reflection in normal pregnancy and control nonpregnant women. Eur J Obstet Gynecol Reprod Biol (2011) 0.81
Improvement in uremic symptoms after increasing daily dialysate volume in patients on chronic peritoneal dialysis with declining renal function. Int Urol Nephrol (2004) 0.80
Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol (2009) 0.80
Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol (2008) 0.80
Is normal saline harmful to the peritoneum? Perit Dial Int (2005) 0.80
Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum. Adv Perit Dial (2004) 0.80
Erectile dysfunction: a warning sign of silent vascular disease. Int Urol Nephrol (2009) 0.80
Peritoneal dialysis in acute renal failure. Perit Dial Int (2003) 0.79
Renal stone disease, elevated iPTH level and normocalcemia. Int Urol Nephrol (2002) 0.79
Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine. Transl Res (2007) 0.79
The variability in ultrafiltration achieved with icodextrin, possibly explained. Perit Dial Int (2009) 0.79
Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution. Blood Purif (2006) 0.78
Colonization-resistant antimicrobial-coated peritoneal dialysis catheters: evaluation in a newly developed rat model of persistent Pseudomonas aeruginosa peritonitis. Perit Dial Int (2002) 0.78
Pulse pressure amplification in relation to body fatness. Br J Clin Pharmacol (2012) 0.78
Peritoneal dialysis in the nursing home. Int Urol Nephrol (2010) 0.78
Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant (2004) 0.78
Association between pulse pressure and mortality in patients undergoing peritoneal dialysis. Perit Dial Int (2009) 0.78
L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats. Perit Dial Int (2002) 0.77
Physiological similarities and differences between renal aging and chronic renal disease. J Nephrol (2007) 0.77
Partitioning total heart rate variability. Int J Cardiol (2009) 0.77
[Hematologic parameters in Polish centenarians]. Wiad Lek (2005) 0.77
Anemia in centenarians. J Am Geriatr Soc (2002) 0.77
Peritoneal effects of intravenous iron sucrose administration in rats. Transl Res (2007) 0.77
Flow index evaluation of 3-D volume flow images: an in vivo and in vitro study. Ultrasound Med Biol (2006) 0.77
Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes? Int Urol Nephrol (2005) 0.77
Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol (2006) 0.77
Morphologic changes in the liver of dialyzed rats--preliminary observations. Adv Perit Dial (2003) 0.76
Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates. Int Urol Nephrol (2009) 0.76
Glucoregulatory hormones and choice of osmotic agent in peritoneal dialysis. Perit Dial Int (2010) 0.76